Company intelligence / Profile preview

Merrell Dow

Kansas City, Missouri, United Statesen.wikipedia.org ↗

Ownership: Private
Employees: ~9808
Development stage: Other

Overview

Merrell Dow (later Marion Merrell Dow) was a major US pharmaceutical company that marketed several widely used drugs including Cardizem, Carafate, Gaviscon, Seldane, Nicorette, and Cepacol. The company is known for having brought to market drugs originally developed elsewhere, and played a major role in the expansion of access to these products in the US pharmaceutical market through the 1980s and 1990s.[2][5]

Therapeutic areas: PsychiatryDermatologyImmunologyGastroenterologyOtherUrologyCardiovascularWomen's Health
Modalities: Small molecule
Industry: Pharma

Beyond the preview

Go deeper on Merrell Dow.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Merrell Dow.

Explore the full profile